Can the incurred CVA charge related to IRB exposures be treated as an eligible provision for the purposes of calculating the own funds reduction for IRB provision shortfall (per Article 159 of Regulation (EU) No 575/2013 (CRR))?
Article 159 of CRR states that "other own funds reductions related to these exposures" can be included in the calculation of the IRB provision shortfall. The incurred CVA charge has gone through the P/L into the equity and hence has reduced the own funds.
Article 159 of Regulation (EU) No 575/2013 (CRR) states that institutions shall subtract the expected loss amount from the general and specific credit risk adjustment and additional value adjustment and "other own funds reductions related to these exposures".
Incurred CVA is not considered as a general and specific credit risk adjustment and additional value adjustment that are subject to the provision defined in Article 159 of the CRR.
Instead, incurred CVA shall be recognised as a reduction in exposure at default (EAD) when calculating the default risk capital as set out under Article 273(6). Accordingly, expected losses can be calculated in all the instances they are used based on the reduced outstanding EAD which reflects incurred CVA.
Update 26.03.2021: This Q&A has been reviewed in the light of the changes introduced to Regulation (EU) No 575/2013 (CRR) and continues to be relevant.